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Scleredema, a medical problem ﬁrst described by Buschke in 1902, is a rare scleromatosis of unknown aetiology, which is character-
ized by wooden, nonpitting induration of the skin. This skin disorder ﬁrst aﬀects the neck and face and may symmetrically spread to the
shoulders, trunk, arms, and legs. We report a case of a 65 year-old hypertensive and diabetic male who presented with marked thickening
of the upper back with obvious peau d’orange changes. Association with other complications of diabetes is not certain and treatment is
diﬃcult, though improvement is possible with optimal glycaemic control. Scleredema diabeticorum is rare and is a cause of signiﬁcant
morbidity in diabetes.
 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Scleredema, a medical problem ﬁrst described by
Buschke in 1902, is a rare sclerodermatosis of unknown
aetiology, which is characterized by wooden, nonpitting
induration of the skin (Chang et al., 2004). This skin disor-
der ﬁrst aﬀects the neck and face and may symmetrically
spread to the shoulders, trunk, arms, and legs. The disorder
often does not aﬀect the hands and the feet.
According to Graﬀ et al., there are three recognized
clinical groups of scleredema. In the ﬁrst group, the disease
starts abruptly after an acute upper respiratory tracthttp://dx.doi.org/10.1016/j.jdds.2014.03.003
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Peer review under responsibility of King Saud University.infection and often resolves in a few months to years, while
in the second group no respiratory tract infection is involved
and has longer duration over a period of years. The third
group consists of long standing scleredema associated with
severe complicated diabetes mellitus (Graﬀ, 1968).
In 1970 scleredema was found to be associated with
diabetes. Scleredema associated with diabetes is said to
improve with good blood glucose control but a prolonged
course may be expected. Dinato et al. in 2010 claimed that
half of the reported cases of scleredema were associated
with diabetes mellitus. The clinical consequences are:
decrease in motility of the shoulders and an impairment
of respiratory function (Dinato et al., 2010).
The pathogenesis of the scleredema diabeticorum is not
known. Martin et al. have noted that some studies have
proposed that nonenzymatic glycosylation of collagen
ﬁbres may alter its degradation. Other hypothesis suggests
that glucose may stimulate ﬁbroblast proliferation and the
synthesis of extracellular matrix components. Immunolog-
ical response has also been postulated, but the lack ofSaud University.
commons.org/licenses/by-nc-nd/3.0/).
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out a T-cell-mediated aetiologic mechanism (Martin
et al., 2011). Thus, there is a need for more studies to focus
on scleredema diabeticorum, its features and its associated
risk factors that may lead to its development.
In this report, we describe the features of scleredema
diabeticorum in a 65 year old diabetic male with long-term
hypertension and poor glycaemic control. We also aim to
identify other risk factors that may lead to the development
of scleredema and to discuss current treatments.Figure 1. Showing peau d’orange changes in the upper back.2. Case
A 65 year old civil servant a known hypertensive of
24 years duration was diagnosed diabetic 2 years ago. He
initially presented at the A & E with hyperglycaemic emer-
gency having had fever, loss of appetite, gradual alteration
of level of consciousness. This was precipitated by a possi-
ble urinary tract infection as he had complaint of dysuria,
frequency and urgency before his level of consciousness
deteriorated. General physical examination revealed a mid-
dle aged man with altered level of consciousness, restless,
severely dehydrated, with deep sighing breathing, he was
not pale and was not jaundiced. He looked obese with a
waist circumference of 121 cm. The admitting blood pres-
sure was 110/70 mmHg with a pulse rate of 124 beats/min.
The admitting blood sugar was 450 mg/dl. The initial
serum electrolyte urea and creatinine showed a slightly ele-
vated urea (10.4 mmol/L) but normal creatinine (112 mg/dl)
and a potassium of 4.2 mmol/L, bicarbonate was 13 mmol/L
and sodium was 142 mmol/L. He was managed aggres-
sively with ﬂuid replacement due to severe dehydration,
Insulin therapy, potassium replacement to correct hypokal-
aemia due to the four hour potassium of 3.4 mmol/L and
antibiotics. He eventually regained consciousness withinFigure 2. H&E  6.3 section shows skin tissue with hyperpigmentation of strathe ﬁrst 24 h on admission and commenced oral feeding
the second day. Intravenous ﬂuid was stopped at that point
and intravenous insulin converted to subcutaneous. Lipid
function test done on the fourth day of admission showed
a total cholesterol of 7.5 mmol/L, HDL of 0.8 mmol/L,
LDL of 4.2 mmol/L and TG of 3.6 mmol/L. Statins (sim-
vastatin) were added to his conventional antihypertensive
therapy of 10 mg lisinopril and 25 mg of hydrochlorothia-
zide which he claimed compliant with. He was discharged
after spending 8 days on admission. Following resolution
of the hyperglycaemic emergency, his blood sugar control
has been suboptimal in the last 2 years despite optimizing
diet and oral hypoglycaemic agents. Routine subcutaneous
insulin was therefore added to his medication with which
he achieved reasonable glycaemic control. Clinical features
of long standing hypertension such as thickened arterial
walls, cardiac hypertrophy and background hypertensive
retinopathy were present. There were no paraesthesia and
intermittent claudication. The renal renal function testtum basalis. There is focal lymphocytic inﬁltration of the reticular dermis.
Figure 3. SH&E  40 section shows the reticular dermis with collagen bands separated by clear spaces.
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of the upper back with obvious peau d’orange changes in
the same region (Fig. 1). Diagnosis of scleredema diabeti-
corum in a patient with type 2 diabetes with suboptimal
glycaemic control was considered and skin biopsy was
taken with a 3.5 mm punch to conﬁrm the diagnosis. The
histology result is shown below (Figs. 2 and 3). No speciﬁc
treatment was instituted for the scleredema diabeticorum,
but he is being followed up to evaluate the eﬀect of optimiz-
ing glycaemic control with the added subcutaneous insulin
on the condition.
3. Histology report (Figs. 2 and 3)
Section shows skin tissue covered by intact epidermis of
keratinizing stratiﬁed epithelia.
The reticular dermis is greatly thickened with bundles of
collagen ﬁbres.
The collagen ﬁbres are broadened and are abnormally
separated by clear spaces.
Here was a dense ﬁbrosis of the papillary dermis with
scanty inﬁltration by inﬂammatory cells mainly lympho-
cytes. There are few ﬁbroblasts within the reticular dermis.
4. Discussion
Scleredema diabeticorum was recognized in 1970 as a
syndrome (Cohn et al., 1970), and presents insidiously with
painless, symmetric thickening of the skin of the upper
back and neck. Spread to the face, shoulder and anterior
torso may occur. The skin retains a non-pitting peau
d’orange quality. Identical changes occur with post strepto-
coccal pharyngitis, though this is sudden and the symptom
remits over time.
Scleredema diabeticorum has a reported a prevalence of
2.5% in patients with type 2 diabetes with a malepreponderance of 10:1 (Cole et al., 1983). It is a disease
of long standing diabetes, associated with obesity. Most
patients have type 2 DM. It has not been reported in
children.
The aetiology of scleredema diabeticorum is unclear.
Glycation of skin collagen and skin hypoxia due to micro-
angiopathy may be key factors. Microscopic examination
shows a thickened dermis with large swollen collagen bun-
dles, particularly type 1 collagen, separated by ground sub-
stance and wide clear spaces. There is no inﬂammation of
the dermis and no increase in the number of dermal ﬁbro-
blasts, features which distinguish scleredema from sclero-
derma. There may be increased numbers of mast cells
and variable expression of glycosaminoglycans. Type 1
subunits of procollagen 1 and 111 messenger RNA
(mRNA) and ﬁbronectin mRNA were elevated in ﬁbro-
blasts of cultured scleredema skin (Cole et al., 1983).
Treatment for scleredema diabeticorum is usually
unsuccessful. Case reports describe treatment with radio-
therapy, low dose methotrexate and prostaglandin E1, 4,
5 (Seyger et al., 1999). Glycaemic control with use of oral
hypoglycaemics is usually very diﬃcult.
A study by Leung and Chong (1998) found that 92% of
twelve Chinese adult patients with scleredema have hyper-
tension requiring medical treatment. The reason for this
very signiﬁcant association is not very clear but the fact
that diabetes and hypertension are known risks for each
other and the attendant dyslipidaemia that mostly compli-
cates long standing diabetes mellitus may be an important
factor. There is therefore a need for future study to look
into these three entities and clearly deﬁne the exact aetiol-
ogy of the associations.
Martin et al. (2011) reported about a 53 year-old white
male with type 2 diabetes mellitus and scleredema who
was given PUVA treatment and physiotherapy with the
amelioration of mobility and acquiring some elasticity of
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control seems not to preclude the development of sclere-
dema in diabetics and that PUVA treatment and physio-
therapy are therapeutic options that seem to be of some
help (Martin et al., 2011).
A study by Thumpimukvatana et al. in 2010 has
described two cases of scleredema diabeticorum with
substantial clinical improvement from a course of medium
dose (60 J/cm2) ultraviolet A1 radiation therapy
(Thumpimukvatana et al., 2010). Furthermore a study by
Kokpol et al. in 2012 reported a case of scleredema diabeti-
corum that was successfully treated by combining local
PUVA treatment with colchicine (Kokpol et al., 2012).
The results were similar to those of Yuksek et al. who
reported a case of scleredema that improved markedly with
low-dose broad-band UVA plus colchicine treatment
(Yuksek et al., 2010).
Konemann et al. in 2004 described the case of a 58-year-
old patient with scleredema of the neck and upper trunk
who was treated twice within 6 months by electron-beam
radiation therapy. The authors concluded that regardless
of the possible mechanisms in pathogenesis and treatment
of scleredema adultorum Buschke, the application of ioniz-
ing radiation is an important, eﬀective and well-tolerated
therapy option in the treatment of severe cases and may
be considered as the ﬁrst-line treatment of this disease
(Konemann et al., 2004).
5. Conclusion
Scleredema diabeticorum is a rare cutaneous disorder
seen in long standing type 2 DM. It has been shown in this
case report that this disorder is characterized by thickening
and induration of upper back. There are various treatments
however, evidence is still lacking as to whether they are
truly eﬀective or not, given the smaller population studied.Conﬂict of interest
None.
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